Interferer Molecule for Controlled Protein Aggregation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for down-regulating protein function, such as RNA interference, lack specificity and control, and are not effective in all organisms, while protein aggregation is a key factor in various diseases, with existing approaches focusing on inhibiting aggregation as a disease-causing phenomenon rather than a controlled process.
Innovation Solution
Development of de novo designed interferer molecules with self-association regions derived from target proteins, fused to a moiety that prevents aggregation, allowing for controlled and specific protein knock-down by inducing co-aggregation, thereby down-regulating the biological function of target proteins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If RNA interference is used to down-regulate protein function, then gene expression can be reduced, but the level of functional reduction cannot be adequately controlled and specificity is not entirely predictable
Solution Approach 1:
The patent introduces an interferer molecule as an intermediary between the researcher and the target protein. This molecule contains a target-specific binding region that provides specificity and a self-association region that enables controlled aggregation. The aggregation propensity can be tuned by modifying the self-association region, allowing precise control over the level of functional reduction while maintaining high specificity for the target protein.
Solution Approach 2:
The patent employs parameter changes by modifying the self-association region of the interferer molecule to control aggregation propensity. By adjusting parameters such as the length, composition, or sequence of the self-association region, researchers can precisely control the degree of protein aggregation and thus the level of functional reduction, achieving reliable and predictable control over gene function.
2Productivity
If protein aggregation is induced as a disease-causing phenomenon, then insoluble deposits form, but this cannot be used as a controlled process for functional down-regulation
Solution Approach 1:
The interferer molecule is segmented into distinct functional regions: a target-specific binding region that ensures specificity and a self-association region that controls aggregation. This segmentation allows independent optimization of each function - the binding region provides target specificity while the self-association region enables tunable aggregation control, transforming an uncontrolled disease process into a precisely controllable tool.
Solution Approach 2:
The patent introduces dynamics by making the aggregation process reversible and tunable. The self-association region can be designed to respond to environmental conditions or regulatory elements, allowing dynamic control over aggregation states. This enables researchers to adjust the level of functional down-regulation in real-time, providing precise control that was previously impossible with irreversible disease-associated aggregation.
3Reliability
If de novo designed interferer molecules with self-association regions are used, then specific and controllable protein knock-down is achieved, but the device complexity increases
Solution Approach 1:
The self-association region serves multiple functions: it enables aggregation for functional down-regulation, provides a mechanism for controlled assembly, and offers a tunable parameter for adjusting activity levels. This multi-functionality reduces the need for separate control mechanisms, simplifying the overall design while maintaining high reliability and specificity in protein knock-down.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution provides a precise and controllable method to down-regulate protein function, offering therapeutic, agricultural, and diagnostic applications by inducing targeted protein aggregation, which can be experimentally adjusted in strength, and is applicable across various organisms.
Implementation Method 1
inducing co-aggregation, thereby down-regulating the biological function of target proteins
Data Source
AI summary
The invention belongs to the field of functional proteomics and, more particularly, to the field of protein aggregation. Described are methods for interfering with the function of a target protein and uses a non-naturally, user-designed molecule, designated as interferor, that has a specificity for a target protein and that induces aggregation upon contact with the target protein. The invention also discloses such interferer molecules and their use in therapeutic applications.